UEEC United Health Products, Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies · OTC · SEC CIK 1096938 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY52.1%
TTM EPS YoY100.0%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE—
ROA-863.4%
ROIC (approx.)—
Asset turnover0.00x
Leverage & solvency
Liabilities / assets1,891.6%
Debt / equity—
Current ratio0.02x
Interest coverage-5.60x
Cash quality & payout
Operating cash flow / net income0.67x
Accruals ratio-286.4%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $0 | $0 | $0 | $37,500 | $59 |
| Cost of revenue | — | — | $0 | $18,644 | $25 |
| Gross profit | — | — | $0 | $18,856 | $34 |
| R&D expense | $269,867 | $355,936 | $598,810 | $624,564 | $237,458 |
| SG&A expense | $1.99M | $1.65M | $1.83M | $2.20M | $29.56M |
| Operating income | -$2.26M | -$2.01M | -$2.43M | -$2.80M | -$29.80M |
| Interest expense | $113,284 | $32,322 | $32,875 | $17,022 | $226,139 |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$2.67M | -$2.00M | -$2.62M | -$1.69M | -$30.55M |
| EBITDA | -$2.25M | -$2.00M | -$2.42M | -$2.80M | -$29.80M |
| EPS (diluted) | -0.01 | -0.01 | -0.01 | — | — |
| Weighted avg. shares (diluted) | 256.98M | 248.17M | 239.08M | — | — |
| Balance sheet | |||||
| Cash & equivalents | $65,249 | $168,883 | $95,420 | $13,377 | $21,799 |
| Inventory | — | $0 | $33,598 | $34,730 | $0 |
| Current assets | $105,392 | $191,683 | $151,822 | $71,039 | $26,799 |
| PP&E, net | — | — | — | — | $0 |
| Intangibles | $24,300 | $28,350 | $32,400 | $36,450 | $0 |
| Total assets | $316,698 | $269,979 | $284,643 | $350,528 | $26,799 |
| Current liabilities | $4.05M | $1.64M | $1.95M | $2.42M | $1.17M |
| Total liabilities | $4.30M | $2.71M | $2.00M | $2.42M | $1.17M |
| Shareholders' equity | -$3.98M | -$2.46M | -$1.71M | -$2.06M | -$1.14M |
| Shares outstanding | 258.69M | 252.41M | 244.78M | 230.87M | 228.67M |
| Cash flow statement | |||||
| Operating cash flow | -$1.19M | -$1.19M | -$2.20M | -$619,720 | -$828,079 |
| Capital expenditure | — | — | — | — | $0 |
| Free cash flow | — | — | — | — | -$828,079 |
| Investing cash flow | $0 | $0 | -$2,850 | -$40,500 | $0 |
| Financing cash flow | $1.08M | $1.27M | $2.29M | $651,798 | $803,802 |
| Depreciation & amortization | $4,050 | $4,050 | $4,050 | $4,050 | $4,050 |
| Stock-based compensation | — | — | — | $483,450 | $26.86M |
| Share buybacks | — | — | $0 | $50,000 | — |
Free plan shows the latest 5 periods; Pro shows all 16 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.